BioCardia, Inc. (BCDA) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.39M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 4.19M USD | Research and Development Expense |
| Selling, general and administration | 3.20M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-7.39M | (m) | (m) | $4.19M | $3.20M | (m) |
| 2026-03-31 | $-7.82M | (m) | (m) | $4.67M | $3.15M | (m) |
| 2025-12-31 | $-8.28M | (m) | (m) | $4.96M | $3.32M | (m) |
| 2025-09-30 | $-8.59M | (m) | (m) | $5.25M | $3.34M | (m) |
| 2025-06-30 | $-8.85M | (m) | (m) | $5.24M | $3.61M | (m) |
| 2025-03-31 | $-8.45M | (m) | (m) | $4.68M | $3.78M | (m) |
| 2024-12-31 | $-8.00M | (m) | (m) | $4.39M | $3.67M | (m) |
| 2024-09-30 | $-7.76M | (m) | (m) | $4.13M | $3.71M | (m) |
| 2024-06-30 | $-8.61M | (m) | (m) | $5.07M | $3.96M | (m) |
| 2024-03-31 | $-10.41M | (m) | (m) | $6.58M | $4.29M | (m) |
| 2023-12-31 | $-11.64M | (m) | (m) | $7.73M | $4.39M | (m) |
| 2023-09-30 | $-12.58M | (m) | (m) | $8.77M | $4.38M | (m) |
| 2023-06-30 | $-13.04M | (m) | (m) | $9.04M | $4.42M | (m) |
| 2023-03-31 | $-12.08M | (m) | (m) | $9.03M | $4.41M | (m) |
| 2022-12-31 | $-11.90M | (m) | (m) | $8.83M | $4.42M | (m) |
| 2022-09-30 | $-12.34M | (m) | (m) | $8.75M | $4.92M | (m) |
| 2022-06-30 | $-11.99M | (m) | (m) | $8.85M | $5.08M | (m) |
| 2022-03-31 | $-12.98M | (m) | (m) | $8.90M | $5.11M | (m) |
| 2021-12-31 | $-12.63M | (m) | $0.00 | $8.56M | $5.09M | (m) |
| 2021-09-30 | $-12.67M | (m) | $0.00 | $8.77M | $4.88M | (m) |
| 2021-06-30 | $-13.81M | (m) | $0.00 | $9.00M | $5.00M | (m) |
| 2021-03-31 | $-13.89M | (m) | (m) | $8.86M | $5.18M | (m) |
| 2020-12-31 | $-15.53M | (m) | $4.00K | $9.81M | $5.86M | (m) |
| 2020-09-30 | $-15.57M | (m) | $41.00K | $9.65M | $6.18M | (m) |
| 2020-06-30 | $-14.95M | (m) | $65.00K | $9.19M | $6.17M | (m) |
| 2020-03-31 | $-15.13M | (m) | $256.00K | $9.18M | $6.23M | (m) |
| 2019-12-31 | $-14.21M | (m) | $358.00K | $8.56M | $6.00M | (m) |
| 2019-09-30 | $-14.34M | (m) | $437.00K | $8.60M | $5.90M | (m) |
| 2019-06-30 | $-14.68M | (m) | $522.00K | $8.85M | $5.79M | (m) |
| 2019-03-31 | $-14.17M | (m) | $466.00K | $8.66M | $5.68M | (m) |
| 2018-12-31 | $-14.10M | (m) | $517.00K | $8.45M | $5.76M | (m) |
| 2018-09-30 | $-13.96M | (m) | (m) | $8.02M | $6.00M | (m) |
| 2018-06-30 | $-13.43M | (m) | (m) | $7.46M | $6.04M | (m) |
| 2018-03-31 | $-13.15M | (m) | (m) | $6.72M | $6.30M | (m) |
| 2017-12-31 | $-12.40M | $479.00K | (m) | $5.80M | $6.39M | -2589.77% |
| 2017-09-30 | $-12.35M | $516.00K | (m) | $5.74M | $6.44M | -2394.19% |
| 2017-06-30 | $-11.00M | $503.00K | (m) | $4.72M | $6.04M | -2186.28% |
| 2017-03-31 | $-9.41M | $535.00K | (m) | $3.92M | $5.33M | -1758.32% |
| 2016-12-31 | $-7.61M | $576.00K | (m) | $3.33M | $4.11M | -1320.83% |
| 2016-09-30 | $5.37M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $327.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $325.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $319.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $291.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $250.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $243.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $231.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $173.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $157.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $98.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $9.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $-60.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $-169.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $-307.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-339.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $-431.00K | $59.00K | (m) | (m) | (m) | -730.51% |
| 2012-06-30 | $-458.00K | $40.00K | (m) | (m) | (m) | -1145.00% |
| 2012-03-31 | $-575.00K | $23.00K | (m) | (m) | (m) | -2500.00% |
| 2011-12-31 | $-618.00K | $12.00K | (m) | (m) | (m) | -5150.00% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-583.00K | $0.00 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |